Cancer Drugs Cost Patients And Payers 189% More In Hospitals vs. Physician Offices – IMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Differences in covered costs were greatest for Avastin, Lemtrada, Perjeta and Rituxan, among 10 commonly prescribed drugs studied, IMS found. Patient cost sharing was an average $134 higher per dose in hospitals.